Short- and Long-Term Outcome of Severe Neonatal Nonhemolytic Hyperbilirubinemia

Abstract

We studied the effects of hyperbilirubinemia on brainstem auditory pathways and neurodevelopmental status in 99 fullterm neonates with severe nonhemolytic hyperbilirubinemia (total serum bilirubin level = 301 to 500 µmol/L) born between 1995 and 2000. These were divided into three groups: group 1, moderate hyperbilirubinemia (n = 30; mean maximum total serum bilirubin = 320.7 µmol/L or 18.9 mg%); group 2, severe hyperbilirubinemia (n= 63; mean maximum total serum bilirubin = 369.0 µmol/L or 21.7 mg%); and group 3, super hyperbilirubinemia (n = 6; mean maximum total serum bilirubin = 457.2 µmol/L or 26.9 mg%). All received phototherapy, and three neonates also had exchange transfusion. Initial brainstem auditory evoked potentials were recorded in all at the mean age of 3.1 months (range 1—9 months). At initial assessment, only nine neonates (9.1%) had abnormal brainstem auditory evoked potentials. All except two returned to normal at 2 years. These two children had a hearing threshold at 50 nHL. We then compared serial brainstem auditory evoked potentials until 2 years for these nine cases with initial abnormal brainstem auditory evoked potentials, and nine cases with initial normal brainstem auditory evoked potentials were recruited for comparison. All 99 children had regular physical, neurologic, visual, and auditory assessments every 3 to 6 months until the age of 3 years. There was no significant correlation between demographic factors (gender, gestational age, or birthweight), maximum total serum bilirubin, and total serum bilirubin at discharge with an abnormal brainstem auditory evoked potential. There was no significant difference in the rate of brainstem auditory evoked potential abnormalities between the three groups: moderate (10%), severe (7.9%), and super (16.7%). All had normal neurodevelopmental status at 3 years. Only two children had transient mild motor delay and hypotonia, and both had normal brainstem auditory evoked potentials. There was no relationship between the abnormalities of the brainstem auditory evoked potentials and neurodevelopmental status. None of the three children receiving exchange transfusion had abnormal brainstem auditory evoked potentials or neurodevelopmental outcome. With the neurophysiologic and clinical outcomes in our cohort with severe nonhemolytic hyperbilirubinemia, we propose that the toxic effect of hyperbilirubinemia on auditory brainstem pathways might be transient provided that prompt treatment is initiated. (J Child Neurol 2006;21:309—315; DOI 10.2310/7010.2006.00058).

Get full access to this article

View all access options for this article.

References

Kiely M. , Drum MA , Kessel K. : Early discharge. Clin Perinatol 1998;25:539—553.

Perstein MA : The late clinical syndrome of poskernicteric encephalopathy. Pediatr Clin North Am 1960;7:665—687.

Hyman CB , Keaster J. , Hanson V. et al: CNS abnormalities after neonatal hemolytic disease and hyperbilirubinemia . Am J Dis Child 1969;117:395—405.

Naeye RL : Amniotic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment . Pediatrics 1978;62:497—503.

Hoyt CB , Bilson FA , Alpins N. : The supranuclear disturbances of gaze in kernicterus. Ann Ophthalmol 1978;10:1487—1492.

Kaga K. , Kitazumi E. , Kodama K. : Auditory brain stem responses of kernicterus infants. Int J Pediatr Otorhinolaryngol 1979; 1: 255—264.

Perlman M. , Fainmesser P. , Sohmer H. , et al: Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics 1983;72:658—664.

Nakamura H. , Takada S. , Shimabuku R. , et al: Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985;75:703—708.

Deltenre P. , Mansbach AL , Bozet C. , et al: Auditory neuropathy: A report on three cases with early onsets and major neonatal illnesses. Electroencephalogr Clin Neurophysiol 1997;104:17—22.

10.

Rance G. , Beer DE , Cone-Wesson B. , et al: Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 1999;20:238—252.

11.

Simmons JL , Beauchaine KL : Auditory neuropathy: Case study with hyperbilirubinemia. J Am Acad Audiol 2000; 11: 337—347.

12.

Wenberg RP , Ahlfors CE , Bikers R. , et al: Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: Improvement with exchange transfusion. J Pediatr 1982;100: 624—626.

13.

Nwaesei CG , Van Aerde J , Boyden M. , Perlman M. : Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics 1984;74:800—803.

14.

Chin KC , Taylor MJ , Perlman M. : Improvement in auditory and visual evoked potentials in jaundiced preterm infants after exchange transfusion. Arch Dis Child 1985;60:714—717.

15.

Kuriyama M. , Tomiwa K. , Konishi Y. , Mikawa H. : Improvement in auditory brainstem response of hyperbilirubinemic infants after exchange transfusions. Pediatr Neurol 1986;2:127—132.

16.

Deliac P. , Demarqur JL , Barberot JP , et al: Brainstem auditory evoked potentials in icteric fullterm newborns: Alterations after exchange transfusion. Neuropediatrics 1990;21:115—118.

17.

Deorari AK , Singh M. , Ahuja GK , et al: One year outcome of babies with severe neonatal hyperbilirubinemia and reversible abnormality in brainstem auditory evoked responses. Indian Pediatr 1994;31:915—921.

18.

Gupta AK , Raj H. , Anand NK : Auditory brainstem responses (ABR) in neonates with hyperbilirubinemia. Indian J Pediatr 1990;57: 705—711.

19.

Agrawal VK , Shukla R. , Misra PK , et al: Brainstem auditory evoked response in newborns with hyperbilirubinemia . Indian Pediatr 1998;35:513—518.

20.

Gupta AK , Mann SB : Is auditory brainstem response a bilirubin neurotoxicity marker? Am J Otolaryngol 1998; 19: 232—236.

21.

Sabatino G. , Verrotti A. , Ramenghi LA , et al: Newborns with hyperbilirubinemia: Usefulness of brainstem auditory response evaluation. Neurophysiol Clin 1996 ;26:363—368.

22.

Funato M. , Teraoka S. , Tamai H. , Shimida S. : Follow-up study of brainstem responses in hyperbilirubinemic newborns treated with exchange transfusion. Acta Paediatr Jpn 1996;38:17—21.

23.

Hosono S. , Ohno T. , Kimoto H. , et al: Follow-up study of auditory brainstem responses in infants with high unbound bilirubin levels treated with albumin infusion therapy. Pediatr Int 2002; 44:488—492.

24.

Rhee CK , Park HM , Jang YJ : Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses. Laryngoscope 1999;109:2005—2008.

25.

Yilmaz Y. , Degirmenci S. , Akdas F. , et al: Prognostic value of auditory response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 200 1; 16: 772—775.

26.

Pallotta R. , Minervino M. , Sabatino G. , et al: Long-term effects of neonatal medium-degree hyperbilirubinemia on brainstem evoked potentials. Pediatr Med Chir 1984;6:273—275.

27.

Katona G. , Farkas Z. , Revai K. , Szabo M. : Follow-up studies of patients with neonatal icterus using acoustic evoked potential audiometry. Orv Hetil 1989;130:1001—1004.

28.

Thoma J. , Gerull G. , Mrowinski D. : A long-term study of hearing in children following neonatal hyperbilirubinemia . Arch Otorhinolaryngol 1986;243:133—137.

29.

Ozmert E. , Eedem G. , Topcu M. , et al: Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr 1996;85:1440—1444.

30.

Ogun B. , Serbetciglu B. , Duman N. , et al: Long-term outcome of neonatal hyper-bilirubinaemia: Subjective and objective audio-logical measures. Clin Otolaryngol 2003; 28: 507—513.

31.

Duman N. , Ozkan H. , Serbetcioglu B. , et al: Long-term follow-up of otherwise healthy term infants with marked hyper-bilirubinaemia: Should the limits of exchange transfusion be changed in Turkey? Acta Paediatr 2004;93:361—367.

32.

Telzrow RW , Snyder DM , Tronick E. , et al: The behavior of jaundiced infants undergoing phototherapy. Dev Med Child Neurol 1980;22:317—326.

33.

Paludetto R. , Mansi G. , Rinaldi P. , et al: The behavior of jaundiced infants treated with phototherapy. Early Hum Dev 1983 ;8:259—267.

34.

Paludetto R. , Mansi G. , Rinaldi P. , et al: Effects of different ways of covering the eyes on behavior of jaundiced infants treated with phototherapy. Biol Neonate 1985;47:1—8.

35.

Ju SH , Lin CH : The effect of moderate non-hemolytic jaundice and phototherapy on newborn behavior. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1991;32:31—41.

36.

Abrol P. , Sankarasubramanian R. : Effect of phototherapy on behaviour of jaundiced neonates. Indian J Pediatr 1998;65: 603—607.

37.

Sisson Trc , Glauson SC , Glauson EM , et al: Retinal changes produced by phototherapy. J Pediatr 1970;77:221—227.

38.

Woody NC , Brodkley MJ : Tanning from phototherapy for neonatal jaundice. J Pediatr 1973;82:1042—1043.

39.

Elder RL : Hazards of ultraviolet radiation from fluorescent lamps to infants during phototherapy. J Pediatr 1974;84:145.

40.

Scheidt PC , Bryla DA , Nelson KB , et al: Phototherapy for neonatal hyperbilirubinemia: Six-year follow-up of the National Institute of Child Health and Human Development clinical trial . Pediatrics 1990;84:455—463.

41.

Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994;94(4 Pt 1):558—565.

42.

Maisels MJ : Neonatal jaundice, in Avery GB (ed): Neonatology. Philadelphia, JB Lippincott, 1987, 592—593.

43.

McMahon JR , Stevenson DK , Oski FA : Physiologic jaundice, in Taeusch HW , Ballard RA (eds): Avery's diseases of the newborn, 7th ed. Philadelphia , WB Saunders, 1998, 1003—1007.

44.

Watchko JF , Oski FA : Bilirubin 20 mg/dl = vigintiphobia. Pediatrics 1983;71:660—663.

45.

Newman TB , Maisels MJ : Evaluation and treatment of jaundice in the term newborn: A kinder, gentler approach. Pediatrics 1992;89:809—818.

46.

Commentaries. Pediatrics 1992;89:819—833.

47.

Dennery PA , Seidman DS , Stevenson DK : Neonatal hyperbilirubinemia. N Engl J Med 2001; 344: 581—590.

48.

Newman TB , Xiong B. , Gonzales VM , et al: Prediction and prevention of super hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154: 1140—1147.

49.

Bhutani VK , Johnson L. , Sivieri EM : Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant bilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6—14.

50.

Bhutani VK , Gourley GR , Adler S. , et al: Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia . Pediatrics 2000;106:E17.

51.

Newman TB , Liljestrand P. , Escobar GJ : Infants with bilirubin levels of 30 mg/dl or more in a large managed care organization. Pediatrics 2003; 111 (6 Pt 1):1303—1311.

52.

Granati B. , Largajolli G. , Rubaltelli FF , et al: Efficacy and safety of the “integral” phototherapy for neonatal hyperbilirubinemia. Results of a follow-up at 6 years of age . Clin Pediatr (Phila) 1984;23:483—486.